ApprovalTrail

Approval · Notice of Compliance 7988 · 2006

STEMETIL: Notice of Compliance 7988

Issued May 30, 2006

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
7988
Date
May 30, 2006
Company
Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Manufacturer name change
Therapeutic class
Antipsychotic - antiemetic

Products in this notice

BrandDINStatus today
STEMETIL01927795Cancelled Post Market
STEMETIL01927779Cancelled Post Market

Medicinal ingredients